| |
| Device | iStent inject Trabecular Micro-Bypass System (Model G2-M-IS) |
| Generic Name | Intraocular pressure lowering implant |
| Applicant | Glaukos Corporation 229 Avenida Fabricante San Clemente, CA 92672 |
| PMA Number | P170043 |
| Date Received | 12/21/2017 |
| Decision Date | 06/21/2018 |
| Product Code |
OGO |
| Docket Number | 18M-2460 |
| Notice Date | 07/09/2018 |
| Advisory Committee |
Ophthalmic |
| Clinical Trials | NCT01461291
|
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the iStent inject® Trabecular Micro-Bypass System (Model G2-M-IS). This device is indicated for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild to moderate primary open-angle glaucoma. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |
| Post-Approval Study | Show Report Schedule and Study Progress |
| Supplements: |
S001 S004 S013 S016 S017 S018 S002 S006 S007 S005 S003 S008 S014 S012 S009 S010 S019 S020 S023 |